$2.95
-0.12-3.91%
At close: -
$2.95
0.000.00%
After Hours: 4:04 PM EDT
Comments
Loading...
Cytek Biosciences Earnings Estimates, EPS & Revenue | NASDAQ:CTKB | Benzinga
Cytek Biosciences reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always include EPS and Revenue results.
Earnings Date
Aug 5
EPS Estimate
$-0.010
Quarterly Revenue Estimate
$46.48M
Annual Revenue
(as of Mar 31)
(as of Mar 31)
$197.05M
Analyze the earnings history of Cytek Biosciences using advanced sorting and filters.
| Get Alert | |||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| CTKB | Cytek Biosciences | -$0.08 | -$0.01 | — | — | $46.62M | $46.48M | — | — | 08/05/2025 | Get Alert |
| CTKB | Cytek Biosciences | -$0.05 | $0.01 | -$0.09 | -1000.00% | $44.86M | $43.30M | $51.93M | 19.93% | 05/08/2025 | Get Alert |
| CTKB | Cytek Biosciences | $0.04 | $0.10 | $0.07 | -30.00% | $58.23M | $59.38M | $57.48M | -3.21% | 02/27/2025 | Get Alert |
| CTKB | Cytek Biosciences | -$0.05 | -$0.01 | $0.01 | 200.00% | $48.00M | $50.70M | $51.50M | 1.58% | 11/05/2024 | Get Alert |
| CTKB | Cytek Biosciences | -$0.03 | -$0.03 | -$0.08 | -166.67% | $49.69M | $49.53M | $46.62M | -5.88% | 08/06/2024 | Get Alert |
| CTKB | Cytek Biosciences | $0.00 | -$0.04 | -$0.05 | -25.00% | $37.09M | $43.55M | $44.86M | 3.01% | 05/08/2024 | Get Alert |
| CTKB | Cytek Biosciences | $0.06 | $0.00 | $0.04 | 100.00% | $48.34M | $56.58M | $58.23M | 2.92% | 02/28/2024 | Get Alert |
| CTKB | Cytek Biosciences | $0.04 | $0.03 | -$0.05 | -266.67% | $40.48M | $55.48M | $48.00M | -13.48% | 11/07/2023 | Get Alert |
| CTKB | Cytek Biosciences | $0.03 | $0.03 | -$0.03 | -200.00% | $40.16M | $45.71M | $49.69M | 8.71% | 08/08/2023 | Get Alert |
| CTKB | Cytek Biosciences | $0.01 | $0.03 | $0.00 | -100.00% | $35.06M | $47.15M | $37.09M | -21.34% | 05/09/2023 | Get Alert |
| CTKB | Cytek Biosciences | $0.04 | $0.05 | $0.06 | 20.00% | $38.89M | $50.22M | $48.34M | -3.75% | 02/28/2023 | Get Alert |
| CTKB | Cytek Biosciences | $0.00 | $0.02 | $0.04 | 100.00% | $34.38M | $43.29M | $40.48M | -6.50% | 11/09/2022 | Get Alert |
| CTKB | Cytek Biosciences | $0.00 | $0.02 | $0.03 | 50.00% | $30.41M | $39.63M | $40.16M | 1.33% | 08/10/2022 | Get Alert |
| CTKB | Cytek Biosciences | $0.01 | $0.00 | $0.01 | 100.00% | $24.27M | $32.51M | $35.06M | 7.86% | 05/11/2022 | Get Alert |
| CTKB | Cytek Biosciences | $0.01 | $0.02 | $0.04 | 100.00% | $30.62M | $36.42M | $38.89M | 6.79% | 02/23/2022 | Get Alert |
| CTKB | Cytek Biosciences | $0.05 | $0.02 | $0.02 | 0.00% | $25.10M | $33.39M | $34.38M | 2.95% | 11/08/2021 | Get Alert |
| CTKB | Cytek Biosciences | $0.06 | — | $0.00 | — | $19.14M | — | $30.41M | — | 09/02/2021 | Get Alert |
Cytek Biosciences (CTKB) Earnings Per Share
Quarterly Earnings Surprise Amount
| Fiscal Quarter | Date Reported | Actual EPS | Estimated EPS | Surprise % |
|---|---|---|---|---|
| Q1 | 2025-05-08 | $-0.09 | $0.01 | -1000.0 % |
| Q4 | 2025-02-27 | $0.07 | $0.10 | -30.0 % |
| Q3 | 2024-11-05 | $0.01 | $-0.01 | 200.0 % |
| Q2 | 2024-08-06 | $-0.08 | $-0.03 | -166.7 % |
Cytek Biosciences (CTKB) Revenue
Quarterly Revenue Surprise Amount
| Fiscal Quarter | Date Reported | Actual Revenue | Estimated Revenue | Surprise % |
|---|---|---|---|---|
| Q1 | 2025-05-08 | $51.93M | $43.30M | 19.9 % |
| Q4 | 2025-02-27 | $57.48M | $59.38M | -3.21 % |
| Q3 | 2024-11-05 | $51.50M | $50.70M | 1.58 % |
| Q2 | 2024-08-06 | $46.62M | $49.53M | -5.88 % |
FAQ
When is Cytek Biosciences (NASDAQ:CTKB) reporting earnings?
Cytek Biosciences (CTKB) is scheduled to report earnings on August 5, 2025. The last reported earnings were for reported on May 8, 2025 for Q1.
What were the latest earnings per share (EPS) for Cytek Biosciences (NASDAQ:CTKB)?
The Actual EPS was $-0.09, which missed the estimate of $0.01.
What were Cytek Biosciences’s (NASDAQ:CTKB) revenues?
The Actual Revenue was $51.9M, which beat the estimate of $43.3M.
Browse earnings estimates, EPS, and revenue on all stocks.
